Evaluating reference-based pricing: initial findings and prospects.
@article{Narine1999EvaluatingRP, title={Evaluating reference-based pricing: initial findings and prospects.}, author={L. Narine and M. Senathirajah and T. Smith}, journal={CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne}, year={1999}, volume={161 3}, pages={ 286-8 } }
Reference-based pricing is a controversial policy mechanism used to control pharmaceutical expenditures. After its implementation in some European countries, the British Columbia government introduced a version of reference-based pricing in October 1995. The authors reviewed previous studies of reference-based pricing in other countries and conducted a preliminary assessment of the impacts of the BC system by analysing secondary utilization and cost data. After the introduction of reference… CONTINUE READING
35 Citations
Effects of Reference Pricing in Pharmaceutical Markets
- Economics, Medicine
- PharmacoEconomics
- 2012
- 75
- Highly Influenced
- PDF
Pharmaceutical policies: effects of reference pricing, other pricing, and purchasing policies.
- Medicine
- The Cochrane database of systematic reviews
- 2014
- 90
Impact of reference-based pricing of nitrates on the use and costs of anti-anginal drugs.
- Medicine
- CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne
- 2001
- 65
- PDF
What is required to evaluate the impact of pharmaceutical reference pricing?
- Economics, Medicine
- Applied health economics and health policy
- 2005
- 29
The evaluation problem in the empirical literature on the impact of pharmaceutical reference pricing
- 2003
Generic drugs: international trends and policy developments in Australia.
- Economics, Medicine
- Australian health review : a publication of the Australian Hospital Association
- 2004
- 46
- PDF
Quantifying components of drug expenditure inflation: the British Columbia seniors' drug benefit plan.
- Medicine
- Health services research
- 2002
- 44
Bias within economic evaluations – the impact of considering the future entry of lower-cost generics on currently estimated incremental cost-effectiveness ratios of a new drug
- Computer Science, Medicine
- ClinicoEconomics and outcomes research : CEOR
- 2015
- 2
- PDF
References
SHOWING 1-7 OF 7 REFERENCES
Opportunity lost: a frontline view of reference-based pricing.
- Medicine
- CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne
- 1996
- 14
A critical analysis of studies of state drug reimbursement policies: research in need of discipline.
- Business, Medicine
- The Milbank quarterly
- 1993
- 164
What is Direct Evidence-Based Policy-Making? Experience from the Drug Benefits Program for Seniors in British Columbia
- Economics
- 1997
- 20
Reference pricing , the European experience
- Health Policy Rev
- 1995
Fixed budgets in the pharmaceutical sector in Germany : effects on costs and quality
- The reform of health care systems : a review of seventeen OECD countries
- 1994
From “ prairie ” to “ garden ” ? Where next for pharmaceuticals in Europe ?
- Eur Bus J
- 1994